{"id":"rhtsh-stimulation","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Hypothyroid symptoms"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"rhTSH is a recombinant form of the pituitary hormone that normally regulates thyroid function. In thyroid cancer patients, rhTSH stimulation increases thyroid-specific gene expression and radioiodine uptake in both normal and malignant thyroid tissue, improving the efficacy of radioactive iodine therapy. This approach allows for effective treatment while minimizing systemic radiation exposure compared to thyroid hormone withdrawal protocols.","oneSentence":"Recombinant human thyroid-stimulating hormone (rhTSH) stimulates thyroid hormone production and uptake to enhance radioactive iodine accumulation in thyroid cancer cells.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:32:07.892Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Differentiated thyroid cancer requiring radioactive iodine therapy"},{"name":"Thyroid cancer with distant metastases"}]},"trialDetails":[{"nctId":"NCT06440850","phase":"PHASE2","title":"Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2024-07-15","conditions":"Thyroid Gland Follicular Carcinoma, Thyroid Gland Oncocytic Carcinoma, Thyroid Gland Papillary Carcinoma","enrollment":21},{"nctId":"NCT04290663","phase":"PHASE3","title":"Systematic Radioiodine Administration Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up","status":"RECRUITING","sponsor":"Centre Francois Baclesse","startDate":"2020-03-02","conditions":"Thyroid Cancer, Intermediate Risk","enrollment":476},{"nctId":"NCT07128394","phase":"NA","title":"Extra Luteinizing Hormone Improve Embryo Quality in IVF Patients With Low LH During Long GnRH-Agonist Treatment","status":"RECRUITING","sponsor":"Nanjing University","startDate":"2024-02-01","conditions":"Infertility, Female, Luteinizing Hormone (LH)","enrollment":590},{"nctId":"NCT02145143","phase":"EARLY_PHASE1","title":"Enhancing Radioiodine (RAI) Incorporation Into BRAF Mutant, RAI-Refractory Thyroid Cancers With the BRAF Inhibitor Vemurafenib: A Pilot Study","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2014-05-20","conditions":"Thyroid Carcinoma","enrollment":12},{"nctId":"NCT03737253","phase":"NA","title":"Hormone Evaluation in Artificial Reproductive Technology","status":"COMPLETED","sponsor":"Lund University","startDate":"2016-09","conditions":"Female Infertility","enrollment":810},{"nctId":"NCT05330130","phase":"PHASE1","title":"Impact of FSH Dosage During Ovarian Stimulation for IVF/ICSI in Granulosa Cells","status":"COMPLETED","sponsor":"ART Fertility Clinics LLC","startDate":"2023-07-05","conditions":"Ovarian Function Insufficiency, Fertility Issues, Infertility,Female","enrollment":6},{"nctId":"NCT04997525","phase":"PHASE4","title":"Estradiol and Progesterone Levels Following Frozen Embryo Transfer","status":"COMPLETED","sponsor":"Copenhagen University Hospital at Herlev","startDate":"2021-04-20","conditions":"Infertility","enrollment":305},{"nctId":"NCT00702338","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05693 (P05713)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-05-15","conditions":"Pregnancy, Neonates","enrollment":1},{"nctId":"NCT00702520","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial 38833 (P05783)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-04-01","conditions":"Pregnancy, Neonates","enrollment":15},{"nctId":"NCT00696800","phase":"PHASE3","title":"A Study to Investigate the Efficacy and Safety of a Single Injection of Corifollitropin Alfa (Organon 36286) for Ovarian Stimulation Using Daily Recombinant Follicle Stimulating Hormone (FSH) as Reference (P05787)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-06-27","conditions":"In Vitro Fertilization","enrollment":1509},{"nctId":"NCT00702845","phase":"PHASE3","title":"To Investigate Efficacy and Safety of a Single Injection of Org 36286 for Ovarian Stimulation Using Daily Recombinant FSH as Reference (Ensure)(P05690/MK-8962-001)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-12-28","conditions":"Infertility","enrollment":397},{"nctId":"NCT00697255","phase":"PHASE2","title":"A Phase 2 Trial to Evaluate if Corifollitropin Alfa (Org 36286), Followed by a Low Daily Dose of hCG or Recombinant FSH Can Induce Monofollicular Growth in Women With WHO Group II Anovulatory Infertility (P05693)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2007-05-15","conditions":"Ovulation Induction","enrollment":8},{"nctId":"NCT06431620","phase":"NA","title":"Safety and Efficacy of Recombinant Human Thyroid Stimulating Hormone for Adjuvant Diagnosis in Patients With Locally Advanced/Metastatic Differentiated Thyroid Cancer","status":"RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2024-06-30","conditions":"Recombinant Human Thyroid Stimulating Hormone","enrollment":15},{"nctId":"NCT06405217","phase":"NA","title":"Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I Treatment","status":"RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2024-04-20","conditions":"DTC - Differentiated Thyroid Cancer, Thyroid Stimulating; Hormone, C, Radiotherapy; Complications","enrollment":30},{"nctId":"NCT04971473","phase":"PHASE3","title":"Comparison of the Efficacy and Safety of rhTSH as An Adjunctive Diagnostic Tool in Differentiated Thyroid Cancer Patients Who Had Been Thyroidectomized Vs. Patients Who After Thyroid Hormone Withdrawal","status":"COMPLETED","sponsor":"Suzhou Zelgen Biopharmaceuticals Co.,Ltd","startDate":"2021-09-10","conditions":"Differentiated Thyroid Cancer","enrollment":201},{"nctId":"NCT04137185","phase":"PHASE1, PHASE2","title":"Clinical Trial of Dose-tolerance, Pharmacokinetics and Iodine Uptake For rhTSH In Post-thyroidectomized Patients","status":"COMPLETED","sponsor":"Suzhou Zelgen Biopharmaceuticals Co.,Ltd","startDate":"2019-06-10","conditions":"Differentiated Thyroid Cancer","enrollment":64},{"nctId":"NCT05670795","phase":"NA","title":"Comparison of Recombinant Follicle Stimulating Hormone and the Combination of Recombinant Follicle Stimulating Hormone With Clomiphene Citrate in Stimulated Intrauterine Insemination Cycles","status":"UNKNOWN","sponsor":"Bezmialem Vakif University","startDate":"2023-01-01","conditions":"Infertility Unexplained","enrollment":254},{"nctId":"NCT00415233","phase":"PHASE3","title":"High Dose vs Low Dose I 131 +/- rhTSH for Differentiated Thyroid Cancer","status":"UNKNOWN","sponsor":"University College, London","startDate":"2006-11","conditions":"Head and Neck Cancer","enrollment":438},{"nctId":"NCT04447183","phase":"PHASE2","title":"The Safety and Effectiveness of rhTSH in Radioiodine Treatment for Patients With Differentiated Thyroid Cancer.","status":"UNKNOWN","sponsor":"Suzhou Zelgen Biopharmaceuticals Co.,Ltd","startDate":"2020-11-23","conditions":"Differentiated Thyroid Cancer","enrollment":120},{"nctId":"NCT04964284","phase":"PHASE3","title":"Efficacy and Safety Study of rhTSH for Adjuvant Radioiodine Ablation Therapy in Patients With Differentiated Thyroid Cancer","status":"UNKNOWN","sponsor":"Suzhou Zelgen Biopharmaceuticals Co.,Ltd","startDate":"2021-10-06","conditions":"Differentiated Thyroid Cancer","enrollment":328},{"nctId":"NCT04858867","phase":"NA","title":"Reinducing Radioiodine-sensitivity in Radioiodine-refractory DTC Using Lenvatinib (RESET)","status":"UNKNOWN","sponsor":"Leiden University Medical Center","startDate":"2022-01-10","conditions":"Differentiated Thyroid Cancer","enrollment":12},{"nctId":"NCT05638529","phase":"PHASE4","title":"Dual Trigger\" in IVF Patients at High Risk of Ovarian Hyper Stimulation Syndrome","status":"UNKNOWN","sponsor":"Mount Sinai Hospital, Canada","startDate":"2019-05-01","conditions":"Ovarian Hyperstimulation Syndrome, Infertility, Female","enrollment":80},{"nctId":"NCT01837745","phase":"PHASE3","title":"Differentiated Thyroid Cancer: is There a Need for Radioiodine Ablation in Low Risk Patients?","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2013-05-13","conditions":"Low Risk Differentiated Thyroid Cancer","enrollment":776},{"nctId":"NCT00454220","phase":"PHASE2","title":"Study to Determine the Dose, the Safety and Effectiveness of a New Drug, Modified Release rhTSH, in Patients With Multinodular Goiter","status":"COMPLETED","sponsor":"Genzyme, a Sanofi Company","startDate":"2007-07","conditions":"Multinodular Goiter","enrollment":96},{"nctId":"NCT03252223","phase":"PHASE4","title":"Ovarian Response to Recombinant Follicle Stimulating Hormone in Women With PCOS","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2017-10-02","conditions":"Polycystic Ovary Syndrome, Healthy, Anovulation","enrollment":33},{"nctId":"NCT01319695","phase":"PHASE1, PHASE2","title":"Corifollitropin Alfa Versus Recombinant Follicle Stimulating Hormone (FSH) in Ovarian Stimulation of Women Undergoing in Vitro Fertilisation","status":"COMPLETED","sponsor":"National and Kapodistrian University of Athens","startDate":"2011-01","conditions":"Infertility","enrollment":140},{"nctId":"NCT04554680","phase":"PHASE2","title":"Clinical Trial in RAI-Refractory Thyroid Carcinoma Evaluating BRAF & MEK Blockade for Re-differentiation Therapy","status":"UNKNOWN","sponsor":"National University Hospital, Singapore","startDate":"2020-12-30","conditions":"Thyroid Cancer","enrollment":5},{"nctId":"NCT01426386","phase":"PHASE2","title":"A Dose-response Trial Using rFSH FE 999049 in Women Undergoing IVF/ICSI Treatment","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2011-09","conditions":"Infertility","enrollment":265},{"nctId":"NCT01969201","phase":"PHASE4","title":"FSH in GnRH-AntagoniST Controlled Ovarian Hyperstimulation Cycles (FAST)","status":"COMPLETED","sponsor":"IBSA Institut Biochimique SA","startDate":"2014-01","conditions":"Infertility","enrollment":710},{"nctId":"NCT03857230","phase":"PHASE1","title":"The Safety and Pharmacokinetics of Primapur and Gonal-f","status":"COMPLETED","sponsor":"IVFarma LLC","startDate":"2015-10-29","conditions":"Area Under Curve, Pharmacokinetics, Absorption","enrollment":28},{"nctId":"NCT00085293","phase":"PHASE2","title":"Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2004-05","conditions":"Recurrent Thyroid Cancer, Stage IVA Follicular Thyroid Cancer, Stage IVA Papillary Thyroid Cancer","enrollment":12},{"nctId":"NCT00926978","phase":"NA","title":"Comparison of Iodine-124 (I-124) and Iodine-131 (I-131) Radiopharmacokinetics in Patients Prepared With Recombinant Human TSH Injection (rhTSH)","status":"TERMINATED","sponsor":"Medstar Health Research Institute","startDate":"2008-12","conditions":"Thyroid Cancer","enrollment":21},{"nctId":"NCT02006680","phase":"","title":"Markers of Pubertal Suppression During Therapy for Precocious Puberty","status":"TERMINATED","sponsor":"University of Minnesota","startDate":"2013-12","conditions":"Central Precocious Puberty","enrollment":4},{"nctId":"NCT02625519","phase":"PHASE4","title":"Efficacy of Urinary Vs Recombinant FSH in Oocyte Donors Based on Receptor N680S FSH Gene Polymorphism (Genodon Trial)","status":"UNKNOWN","sponsor":"Instituto Bernabeu","startDate":"2015-12","conditions":"Reproductive Techniques, Assisted","enrollment":180},{"nctId":"NCT01183143","phase":"PHASE3","title":"Convenience and Safety of Assisted Reproductive Technology Procedures Using a Gonal-F Filled by Mass (Fbm) Liquid Formulation Applied by Pen for Ovulation Induction and In-vitro Fertilization","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2004-05-11","conditions":"Infertility, Ovulation Induction, In-Vitro Fertilization","enrollment":215},{"nctId":"NCT00249834","phase":"PHASE4","title":"Safety and Efficacy of Pre-defined, Fixed Dose of Gonal-f Pen Based on Subject Baseline Characteristics in Subjects Undergoing in Vitro Fertilization (IVF)","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2004-09-22","conditions":"Infertility","enrollment":166},{"nctId":"NCT01110707","phase":"PHASE2","title":"A Randomised, Phase II, Comparative Study With a Parallel Control for Evaluating the Efficacy and Safety of Combined Treatment of Lutropin Alpha and Recombinant Human Luteinizing Hormone in the Middle of the Controlled Ovarian Stimulation Follicular Phase in Women With Reduced Ovarian Reserve","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2005-01-10","conditions":"Infertility, Ovulation Induction","enrollment":131},{"nctId":"NCT02069808","phase":"PHASE4","title":"Efficacy of Recombinant FSH/GnRH Antagonist Protocol With and Without LH Adjunct for Egg Bank Donation","status":"COMPLETED","sponsor":"Michigan Reproductive Medicine","startDate":"2014-04","conditions":"Egg Donation","enrollment":38},{"nctId":"NCT01687712","phase":"PHASE3","title":"Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF","status":"COMPLETED","sponsor":"Fertility Biotech AG","startDate":"2013-11-25","conditions":"Infertility","enrollment":1100},{"nctId":"NCT03118830","phase":"PHASE4","title":"Long Protocol and Freeze All Embryos vs Antagonist Protocol With Fresh Embryo Transfer in PCOS Patients Undergoing ICSI","status":"COMPLETED","sponsor":"Cairo University","startDate":"2017-04-21","conditions":"Invitro Fertilization","enrollment":204},{"nctId":"NCT01871532","phase":"PHASE4","title":"Low-dose Gonal-f® in Ovulation Induction","status":"TERMINATED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2013-07","conditions":"Infertility, Monofollicular Development","enrollment":24},{"nctId":"NCT01403324","phase":"NA","title":"Comparison of Dosimetry After rhTSH or Withdrawal of Thyroid Hormone in Metastatic or Locally Advanced Thyroid Cancer","status":"TERMINATED","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2011-09","conditions":"Thyroid Cancer, Metastases","enrollment":4},{"nctId":"NCT02349945","phase":"PHASE2, PHASE3","title":"FSH Receptor Polymorphism p.N680S and Efficacy of FSH Therapy","status":"COMPLETED","sponsor":"Azienda USL Modena","startDate":"2011-01","conditions":"Male Infertility","enrollment":88},{"nctId":"NCT01653743","phase":"PHASE3","title":"Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2012-09","conditions":"Anovulation, Oligo-ovulation, Hypothalamic-pituitary Dysfunction","enrollment":81},{"nctId":"NCT02140515","phase":"PHASE4","title":"Comparison of Assisted Reproductive Technology (ART) Outcomes Between Two Protocols of Induction of Ovulation in Patients With Hypogonadotropic Hypogonadism","status":"UNKNOWN","sponsor":"Royan Institute","startDate":"2012-11","conditions":"Infertility","enrollment":90},{"nctId":"NCT00137891","phase":"PHASE1","title":"Study Comparing Thyrogen Versus a Modified Release of Recombinant Human Thyroid Stimulating Hormone","status":"COMPLETED","sponsor":"Genzyme, a Sanofi Company","startDate":"2005-06","conditions":"Healthy","enrollment":46},{"nctId":"NCT00295763","phase":"PHASE3","title":"A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen.","status":"COMPLETED","sponsor":"Genzyme, a Sanofi Company","startDate":"2006-05","conditions":"Differentiated Thyroid Cancer","enrollment":61},{"nctId":"NCT02244866","phase":"NA","title":"Efficacy of Pergoveris in Aged IVF Patients","status":"COMPLETED","sponsor":"Vietnam National University","startDate":"2012-10","conditions":"Infertility","enrollment":240},{"nctId":"NCT01945125","phase":"NA","title":"Effects of THW and rhTSH in Glomerular Filtration Rate During RIT","status":"COMPLETED","sponsor":"University of Sao Paulo General Hospital","startDate":"2011-10","conditions":"Other Impaired Renal Function Disorder","enrollment":28},{"nctId":"NCT01100333","phase":"","title":"GONAL-f CONSORT (Consistency in r-hFSH Starting Doses for Individualised Treatment)","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2008-04","conditions":"Infertility","enrollment":2552},{"nctId":"NCT01115725","phase":"","title":"A Study to Evaluate the Ease of Use, Local Tolerance, Safety and Effectiveness of Gonal-f® (Filled-by-mass in a Prefilled Pen)","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2005-11","conditions":"Infertility","enrollment":76},{"nctId":"NCT01111084","phase":"","title":"A Prospective, Multi-centric Observational Study to Determine the Mono-bifollicular Development in Infertile Women Subjected to Ovulation Induction With Follitropin α","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2004-03","conditions":"Ovulation Induction","enrollment":410},{"nctId":"NCT01080729","phase":"","title":"An Observational Study to Compare the Dose of Gonal-fTM FbM Prescribed by the Doctor With the Recommendation of the Dose Calculator Consort and to Evaluate the Ease of Use of Pre-filled Pen of Gonal-fTM FbM Pen","status":"TERMINATED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2009-02","conditions":"Multifollicular Stimulation","enrollment":25},{"nctId":"NCT00298025","phase":"PHASE4","title":"A Study to Compare the Safety and Efficacy of Cetrotide® 3 Milligram (mg) Versus Antagon™ in Women Undergoing Ovarian Stimulation","status":"COMPLETED","sponsor":"EMD Serono","startDate":"2003-09","conditions":"Infertile Women Undergoing Assisted Reproductive Technology (ART)","enrollment":185},{"nctId":"NCT01100346","phase":"","title":"Predictive Factors of Ovarian Response in Ovulation Induction With Intrauterine Insemination of a Gonal-f Low-dose Regimen","status":"TERMINATED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2010-01","conditions":"Infertility","enrollment":30},{"nctId":"NCT01225835","phase":"PHASE4","title":"Progesterone Serum Levels in Subfertile Female Patients Undergoing in Vitro Fertilisation (IVF)","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2010-10","conditions":"Infertility","enrollment":124},{"nctId":"NCT01075815","phase":"PHASE2","title":"A Clinical Trial to Determine the Effect of Lutropin Alfa on Embryo Quality and Implantation Rate in Advanced Reproductive Age","status":"TERMINATED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2008-11","conditions":"Infertility, Ovulation Induction","enrollment":76},{"nctId":"NCT01081626","phase":"PHASE4","title":"Recombinant Follicle Stimulating Hormone (FSH) (Gonal-f®): Use in Ovulation Induction","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2009-03","conditions":"Ovulation Induction","enrollment":310},{"nctId":"NCT00829244","phase":"PHASE4","title":"CONSORT Randomized Controlled Trial in Assisted Reproductive Technology","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2008-08","conditions":"Infertility","enrollment":200},{"nctId":"NCT01185704","phase":"PHASE3","title":"Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART)","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2008-11","conditions":"Polycystic Ovarian Syndrome","enrollment":136},{"nctId":"NCT01210144","phase":"PHASE4","title":"EXpression PRofile Endometrium Samples Study","status":"TERMINATED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2008-08","conditions":"In Vitro Fertilization","enrollment":27},{"nctId":"NCT01084265","phase":"PHASE3","title":"A Study Using Recombinant Human Luteinizing Hormone (r-hLH, Luveris®) in the Treatment of Chinese Women With Hypogonadotropic Hypogonadism","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2004-02","conditions":"Hypogonadism","enrollment":31},{"nctId":"NCT00328926","phase":"PHASE4","title":"Luveris® (Lutropin Alfa for Injection) in Women With Hypogonadotropic Hypogonadism (Luteinizing Hormone [LH] Less Than [<] 1.2 International Unit Per Liter [IU/L])","status":"TERMINATED","sponsor":"EMD Serono","startDate":"2006-03","conditions":"Hypogonadotropic Hypogonadism","enrollment":11},{"nctId":"NCT00604318","phase":"PHASE4","title":"Quality of Life, Recombinant TSH (Thyrogen) and Thyroid Cancer","status":"COMPLETED","sponsor":"Copenhagen University Hospital at Herlev","startDate":"2008-02","conditions":"Thyroid Cancer","enrollment":56},{"nctId":"NCT01760278","phase":"PHASE4","title":"Assessment of Implantation Potential of Embryos by Time-lapse Technology","status":"UNKNOWN","sponsor":"Bloom IVF and Fertility Centre","startDate":"2012-12","conditions":"Embryo/Fetus Death, Blastocyst Disintegration, Aneuploidy","enrollment":200},{"nctId":"NCT01662180","phase":"","title":"Predicting Ovarian Response in Artificial Insemination With Low Stimulation","status":"UNKNOWN","sponsor":"Isala","startDate":"2012-12","conditions":"Subfertility","enrollment":510},{"nctId":"NCT00884221","phase":"PHASE3","title":"MENOPUR in Gonadotrophin-releasing Hormone (GnRH) Antagonist Cycles With Single Embryo Transfer","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2009-07","conditions":"Infertility","enrollment":749},{"nctId":"NCT00669786","phase":"PHASE3","title":"Human Menopausal Gonadotropin (HMG) vs Recombinant Follicle Stimulating Hormone (rFSH) in Gonadotropin Releasing Hormone (GnRH) Antagonist Cycles","status":"COMPLETED","sponsor":"Instituto Valenciano de Infertilidad, IVI VALENCIA","startDate":"","conditions":"Ovarian Stimulation","enrollment":""},{"nctId":"NCT00553293","phase":"PHASE4","title":"Nordic Luveris Study","status":"COMPLETED","sponsor":"Rigshospitalet, Denmark","startDate":"2003-08","conditions":"Infertility, In Vitro Fertilization","enrollment":526}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":133,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Thyrogen"],"phase":"phase_3","status":"active","brandName":"rhTSH stimulation","genericName":"rhTSH stimulation","companyName":"Gustave Roussy, Cancer Campus, Grand Paris","companyId":"gustave-roussy-cancer-campus-grand-paris","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Recombinant human thyroid-stimulating hormone (rhTSH) stimulates thyroid hormone production and uptake to enhance radioactive iodine accumulation in thyroid cancer cells. Used for Differentiated thyroid cancer requiring radioactive iodine therapy, Thyroid cancer with distant metastases.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}